Reading time is 2 mins
.
.
SCIENTISTS HAVE STUDIED NOT ONLY FOR CORONAVIRUS IN 2021… AMAZING AND PROMISING MEDICAL INVENTIONS
Last year, our eyes were on COVID-19 vaccines. While scientists were focusing on this issue, studies were also carried out for the remedies of different health problems. We have scanned the literature for medical inventions that do not sound big enough and deservedly; in 2021, there have been many exciting developments from malaria to candida, from anterior cruciate ligament tear treatment to a method that can test for more than 50 cancers. Here are promising works.
.
DNA ENZYMES
In 2020, the groundbreaking ‘gene editing technology’ began to be used in medical treatments in 2021. The treatment, which will be summarized as cutting pieces of DNA and producing enzymes that restore them to their normal functions, was used in humans for the first time this year. The President of the American Heart Association has announced that promising first steps have been taken in the development of such methods that can also be used to treat rare genetic heart diseases, especially in children.
.
THE MALARIA VACCINE
The World Health Organization (WHO) has approved a malaria vaccine produced in sub-Saharan Africa for at-risk children. This approval marks a turning point for children’s health and malaria control. The launch of a licensed Ebola vaccine was also counted among the most important developments of 2021 in the WHO’s end assessment. Also, a biotechnology company has produced monoclonal antibodies targeting Ebola, that is, molecules that help defeat the invaders. The American Drug and Food Administration (FDA) has also granted this treatment an emergency use permit.
.
CANCER TESTING
Cancer tests have been conducted for a long time. In the new technology, early signs of more than 50 species can be detected at a time, and DNA fragments that indicate the presence of cancer are searched for.
.
MIGRAINE MEDICATION
A new type of drug, which began its experimental work in 2018, blocks the activity of a molecule called peptide (CGRP) associated with the calcitonin gene, which spikes during migraines. The drug, which received FDA approval in 2021, heralds a new era in the treatment of migraine.
.
TREATMENT OF PROGERIA
Progeria is a genetic disease that causes premature aging characteristics in about 400 children worldwide. Until recently, there was no treatment to slow the progression of the disease. In gene therapy that received FDA approval last year, both patients’ life expectancy was extended and symptoms were reduced/delayed.
.
THE TORN IMPLANT
The treatment of ACL or anterior cruciate ligament rupture so far has been both difficult and painful. Moreover, it did not lead to a full recovery. The short name of the new system is BEAR. Its inventor Doctor, with a small attempt at treatment, a protein-based sponge prepared with the patient’s own blood is placed at the ends of the torn anterior cruciate ligament.
.
THE CANDIDA PILL
Scientists have developed a drug to block the increase of candida, which is involved in vaginal yeast infections, for the first time in more than 20 years. The drug, which is released as two pills and has received approval, also prevents the fungus from recurring by staying in the system for 15 days.
.
ARTIFICIAL BREAST MILK
Two scientists have produced the first breast milk in a laboratory setting this year. Biomilq is the first cell-cultured milk with nutritional components and complexity of breast milk. Making it from lab-grown breast cells puts it on the ‘breakthrough’ list. This artificial breast milk produced in the laboratory is not yet at the stage of being sold on the market.
.
.
.
.
Turkey's world-renowned organ transplant specialist. Dr. Demirbaş has 104 international publications and 102 national publications.
Physician's Resume:
Born on August 7, 1963 in Çorum, Prof. Dr. Alper Demirbaş has been continuing his work as the President of MedicalPark Antalya Hospital Organ Transplantation Center since 2008.
Prof. who performed the first tissue incompatible kidney transplant in Turkey, the first blood type incompatible kidney transplant, the first kidney-pancreas transplant program and the first cadaveric donor and live donor liver transplant in Antalya. Dr. As of August 2016, Alper Demirbaş has performed 4900 kidney transplants, 500 liver transplants and 95 pancreas transplants.
In addition to being the chairman of 6 national congresses, he has also been an invited speaker at 12 international and 65 national scientific congresses. Dr. Alper Demirbaş was married and the father of 1 girl and 1 boy.
Awards:
Eczacibasi Medical Award of 2002, Akdeniz University Service Award of 2005, Izder Medical Man of the Year Award of 2006, BÖHAK Medical Man of the Year Award of 2007, Sabah Mediterranean Newspaper Scientist of the Year Award of 2007, ANTIKAD Scientist of the Year Award of 2009, Social Ethics Association Award of 2010, Işık University Medical Man of the Year Award of 2015, VTV Antalya's Brand Value Award of 2015.
Certificates:
Doctor of Medicine Degree Hacettepe University Faculty of Medicine Ankara, General Surgeon Ministry of Health Turkey EKFMG (0-477-343-8), University of Miami School of Medicine Member of Multiple Organ Transplant, ASTS Multiorgan Transplant Scholarship. Lecturer at Kyoto University. Lecturer at University of Essen, Research assistant at the University of Cambridge .
Professional Members:
American Society of Transplant Surgeons, American Transplantation Society Nominated, Middle East and Southern Africa Council Transplantation Society 2007, International Liver Transplantation Association, Turkish Transplantation Association, Turkish Society of Surgery, Turkish Hepatobiliary Surgery Association.
Disclaimer:
Our website contents consist of articles approved by our Web and Medical Editorial Board with the contributions of our physicians. Our contents are prepared only for informational purposes for public benefit. Be sure to consult your doctor for diagnosis and treatment.